Published in Neuropharmacology on June 01, 1985
On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction. Br J Pharmacol (1988) 1.05
Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br J Pharmacol (1994) 0.96
The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade. Br J Pharmacol (1987) 0.87
4-Aminopyridine-induced increase in basal and stimulation-evoked [3H]-NA release in slices from rat hippocampus: Ca2+ sensitivity and presynaptic control. Br J Pharmacol (1991) 0.83
A study of the actions of P1-purinoceptor agonists and antagonists in the mouse vas deferens in vitro. Br J Pharmacol (1988) 0.82
Colocalization of ATP and nicotinic ACh receptors in the identified vagal preganglionic neurone of rat. J Physiol (1995) 0.82
Presynaptic P1-purinoceptors in jejunal branches of the rabbit mesenteric artery and their possible function. J Physiol (1988) 0.79
Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol (1977) 2.10
Influence of angiotensin, vasopressin or changes in flow rate on vasoconstriction, changes in volume and [3H]-noradrenaline release following postganglionic sympathetic nerve stimulation in the isolated cat spleen. Br J Pharmacol Chemother (1966) 1.20
Synthesis and release of prostaglandins by rat brain synaptosomal fractions. J Neurochem (1976) 1.17
Influence of isoproterenol, hydralazine and phentolamine on the renin activity of plasma and renal cortex of rats. Eur J Pharmacol (1970) 1.14
The importance of endogenous prostaglandins other than prostacyclin, for the modulation of contractility of some rabbit blood vessels. Br J Pharmacol (1984) 1.14
Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.01
Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline. Br J Pharmacol (1987) 1.01
Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.00
The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin. Br J Pharmacol (1986) 0.97
Potentiation and abolition of the increase in plasma renin activity seen after hypotensive drugs in rats. Eur J Pharmacol (1972) 0.96
The mechanism of the drinking response to some hypotensive drugs: activation of the renin-angiotensin system by direct or reflex-mediated stimulation of -receptors. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.96
Release of prostaglandins from isolated cat spleen by angiotensin and vasopressin. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.95
Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.95
Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandins E2 and F2 alpha. Psychopharmacology (Berl) (1983) 0.94
Effect of prostaglandins D2, E2 and F2alpha on catecholamine release from slices of rat and rabbit brain. Eur J Pharmacol (1981) 0.94
Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13-butyrate. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.94
Presynaptic modulation of acetylcholine, noradrenaline, and serotonin release in the hippocampus of aged rats with various levels of memory impairments. Brain Res Bull (2003) 0.93
Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.91
Are cerebral prostanoids of astroglial origin? Studies on the prostanoid forming system in developing rat brain and primary cultures of rat astrocytes. Brain Res (1987) 0.91
Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator of protein kinase C. Eur J Pharmacol (1986) 0.91
Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur J Pharmacol (1985) 0.90
Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit. J Neurochem (1986) 0.89
Modulation of electrically evoked acetylcholine release in cultured rat septal neurones. J Neurochem (2001) 0.89
Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum. J Neurochem (2003) 0.89
[Inhibition by nephrectomy of drinking induced by hypotensive agents in rats]. Experientia (1971) 0.88
Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. J Neurochem (1991) 0.88
Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release. Eur J Pharmacol (1988) 0.88
Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma. Eur J Pharmacol (1981) 0.87
The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade. Br J Pharmacol (1987) 0.87
Protein kinase C and presynaptic modulation of acetylcholine release in rabbit hippocampus. Br J Pharmacol (1988) 0.86
Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.86
Role of vasopressin in the ACTH response to isoprenaline. Eur J Pharmacol (1982) 0.86
[Effect of various blood pressure-lowering drugs on water uptake and output in rats]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.86
Effect of pretreatment with 6-hydroxydopamine on the uptake and metabolism of catecholamines by the isolated perfused rat heart. Br J Pharmacol (1971) 0.85
[Magnitude of effects for aspects of health behavior--results of a cross-sectional study of Hamburg residents. I]. Offentl Gesundheitswes (1986) 0.84
Comparison of the prostanoid synthesizing capacity in homogenates from primary neuronal and astroglial cell cultures. Biochem Pharmacol (1984) 0.84
[Pharmacokinetic studies on 3H-hexoprenaline in the rat]. Arzneimittelforschung (1973) 0.84
Uptake kinetics and metabolism of 7-3H-dopamine in the isolated perfused rat heart. Br J Pharmacol (1971) 0.84
Presynaptic kappa-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the alpha 2-adrenoceptors. J Neurochem (1989) 0.84
The importance of Ca2+-mediated phospholipase A2 activation for stimulus-evoked PGE2-release from rabbit splenic capsular strips. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.84
N-ethylmaleimide (NEM) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.84
[DNA-, RNA-, lipidsynthesis and the specific activity of the glucose-6-phosphate dehydrogenase and glucose-6-phosphatase in the different morphologic stages of Plasmodium vinckei]. Tropenmed Parasitol (1975) 0.84
False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Br J Pharmacol (1986) 0.84
On the relation between contraction and prostaglandin release in rabbit mesenteric blood vessels. Eur J Pharmacol (1980) 0.84
Inhibition of central neurotransmitter release by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.84
Role of dopamine receptors in the modulation of acetylcholine release in the rabbit hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.83
[Glutathionestatus of Plasmodium vinckei parasitized erythrocytes in correlation to the intraerythrocytic development of the parasite (author's transl)]. Tropenmed Parasitol (1975) 0.83
Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynanthine as alpha-adrenoceptor antagonists and 5-HT-receptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.83
Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor. Endocrinology (1984) 0.83
[Endoscopic pretherapeutic clipping for gastrointestinal tumors. A method for exact definition of the target volume]. Strahlenther Onkol (2000) 0.83
Regional distribution of arachidonic acid metabolites in rat brain following convulsive stimuli. Prostaglandins (1981) 0.83
Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.83
Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release. Pflugers Arch (1980) 0.83
Why do some antidepressants promote suicide? Psychopharmacology (Berl) (1986) 0.82
3,4-Diaminopyridine-induced noradrenaline release from CNS tissue as a model for action potential-evoked transmitter release: effects of phorbol ester. Eur J Pharmacol (1989) 0.82
A detailed study on the effects of protein kinase C activation on alpha-2 adrenoceptor-coupled modulation of norepinephrine release in hippocampus. J Pharmacol Exp Ther (1991) 0.82
Particulate matter inhalation during hay storing activity induces systemic inflammation and platelet aggregation. Eur J Appl Physiol (2009) 0.82
Phorbol ester-mediated enhancement of hippocampal noradrenaline release: which ion channels are involved? Eur J Pharmacol (1988) 0.82
Influence of serotonin on water intake and the renin-angiotensin system in the rat. Arch Int Pharmacodyn Ther (1974) 0.81
Vasopressin and beta-endorphin release after osmotic and non-osmotic stimuli: effect of naloxone and dexamethasone. Eur J Pharmacol (1982) 0.81
The autoinhibitory feedback control of acetylcholine release in human neocortex tissue. Brain Res (1992) 0.81
Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro. J Pharmacol Exp Ther (1992) 0.81
Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.81
Potential anticonvulsive properties of endogenous prostaglandins formed in mouse brain. Brain Res (1982) 0.81
Possible involvement of protein kinase C (PKC) in the regulation of electrically evoked serotonin (5-HT) release from rabbit hippocampal slices. Eur J Pharmacol (1987) 0.81
Naloxone promotes stimulus-evoked vasopressin release in vivo. Eur J Pharmacol (1980) 0.81
Evidence for inhibition by beta-endorphin of vasopressin release during foot shock-induced stress in the rat. Neuroendocrinology (1982) 0.81
P2 purinoceptors modulating noradrenaline release from sympathetic neurons in culture. Eur J Pharmacol (1994) 0.81
Staurosporine counteracts the phorbol ester-induced enhancement of neurotransmitter release in hippocampus. Arch Int Pharmacodyn Ther (1989) 0.80
Identification of mechanisms involved in the modulation of release of noradrenaline in the hippocampus of the rabbit in vitro. Neuropharmacology (1984) 0.80
[15-Hydroxyprostaglandin dehydrogenase from human placenta, II. Steady state kinetics and influence of prostaglandin F2alpha analogues (author's transl)]. Hoppe Seylers Z Physiol Chem (1975) 0.80
Lesions of supracallosal or infracallosal hippocampal pathways in the rat: behavioral, neurochemical, and histochemical effects. Behav Neural Biol (1994) 0.80
Increased prostaglandin formation in rat brain following systemic application of kainic acid. Brain Res (1987) 0.80
Studies on the interaction between presynaptic alpha 2-adrenoceptors and adenosine A1 receptors located on noradrenergic nerve terminals. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.80
Presynaptic P1-purinoceptors in jejunal branches of the rabbit mesenteric artery and their possible function. J Physiol (1988) 0.79
Postnatal development of opioid receptors modulating acetylcholine release in hippocampus and septum of the rat. Brain Res Dev Brain Res (2000) 0.79
[On the mechanism of potentiation of catecholamine action following chronic postganglionic sympathetic denervation]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.79
Effect of extracellular dopamine on the release of dopamine in the rabbit caudate nucleus: evidence for a dopaminergic feedback inhibition. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.79
Does the release of acetylcholine in septal slices originate from intrinsic cholinergic neurons bearing p75(NTR) receptors? A study using 192 IgG-saporin lesions in rats. Neuroscience (2003) 0.79
Presynaptic alpha 2-adrenoceptors inhibit calcium influx in terminals of chicken sympathetic neurons and noradrenaline release evoked by nicotinic stimulation. Neurosci Lett (1994) 0.79
Characterization of cysteinyl-leukotriene formation in primary astroglial cell cultures. J Pharm Pharmacol (1990) 0.79
On the relation between release of prostaglandins and contractility of rabbit splenic capsular strips. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.79
Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin. Brain Res (1995) 0.79
P2-purinoceptor induced prostaglandin synthesis in primary rat astrocyte cultures. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.79
alpha-Adrenoceptor-mediated inhibitory effect of the sympathetic nervous system on the isoprenaline-induced increase in plasma renin concentration. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.79
Synaptosomal calcium uptake systems: prostaglandins are probably not involved in the regulation of calcium fluxes into and within the nerve endings. J Neurochem (1982) 0.79